Stimulatory effect of antidepressants on the production of IL-6

International Immunopharmacology

Volumn 4, Issue 2, 2004, Pages 185-192

  Kubera, Marta ^a   Kenis, Gunter ^b   Bosmans, Eugene ^c   Kajta, Małgorzata ^a   Basta Kaim, Agnieszka ^a   Scharpe, Simon ^d   Budziszewska, Bogusława ^a   Maes, Michael ^b,e,f  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c Eurogenetics   (Belgium)

^d UNIVERSITY OF ANTWERP   (Belgium)

^e Clinical Research Center for Mental Health of Antwerp   (Belgium)

^f VANDERBILT UNIVERSITY   (United States)

Author keywords

Antidepressants; IL 6; Phytohemagglutinin

Indexed keywords

5 HYDROXYTRYPTOPHAN; ANTIDEPRESSANT AGENT; FLUOXETINE; IMIPRAMINE; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; PHYTOHEMAGGLUTININ; TUMOR NECROSIS FACTOR ALPHA; VENLAFAXINE;

ADULT; AGE; ARTICLE; CELL STIMULATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEPRESSION; DRUG EFFICACY; DRUG RESISTANCE; FEMALE; HUMAN; IMMUNOSTIMULATION; INCUBATION TIME; MALE; NORMAL HUMAN; PRIORITY JOURNAL;

5-HYDROXYTRYPTOPHAN; ADULT; AGE FACTORS; AGING; ANTIDEPRESSIVE AGENTS; BLOOD CELLS; CYCLOHEXANOLS; DEPRESSIVE DISORDER; DRUG COMBINATIONS; FEMALE; FLUOXETINE; HUMANS; IMIPRAMINE; INFLAMMATION; INTERLEUKIN-6; MALE; MIDDLE AGED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 1542302694     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2003.11.006     Document Type: Article

References (40)

1. Maes M., Smith R., Scharpe S. The monocyte T-lymphocyte hypothesis of major depression. Psychoneuroendocrinology. 20:1995;111-116.
2. Slużewska A., Rybakowski J.K., Sobieska M., Bosmans E., Pollet H., Wiktorowicz K. Increased levels of alpha-1-acid glycoprotein and interleukin-6 in refractory depression. Depression. 39:1996;149-155.
3. Kubera M., Maes M. Serotonin-immune interactions in major depression. Petterson, Kordon, Christen Neuro-Immune Interactions in Neurologic and Psychiatric Disorders. 2000;79-87 Springer-Verlag, Berlin.
4. Yirmiya R. Endotoxin produces a depressive-like syndrome in rats. Brain Res. 711:1996;163-174.
5. Anisman H., Kokkinidis L., Borowski T., Merali Z. Differential effects of interleukin (IL)-1 beta, IL-2 and IL-6 on responding for rewarding lateral hypothalamic stimulation. Brain Res. 779:1998;177-187.
6. Kubera M., Symbirtsev A., Basta-Kaim A., Borycz J., Roman A., Papp M.et al. Effect of chronic treatment with imipramine on interleukin 1 and interleukin 2 production by splenocytes obtained from rats subjected to a chronic mild stress model of depression. Pol. J. Pharmacol. 48:1996;503-506.
7. Kubera M., Holan V., Basta-Kaim A., Roman A., Borycz J., Shani J. Effect of desipramine on immunological parameters in mice, and their reversal by stress. Int. J. Immunopharmacol. 20:1998;429-438.
8. Kubera M., Maes M., Holan V., Basta-Kaim A., Roman A., Shani J. Prolonged desipramine treatment increases the production of interlekin-10, an anti-inflammatory cytokine, in C57BL/6 mice subjected to the chronic mild stress model of depression. J. Affect. Disord. 63:2001;171-178.
9. Suzuki E., Shintani F., Kanba S., Asai M., Nakaki T. Induction of interleukin-1 receptor antagonist mRNA by chronic treatment with various psychotropics in widespread area of rat brain. Neurosci. Lett. 215:1996;201-204.
10. Xia Z., DePierre J., Nassberger L. Tricyclic antidepressants inhibit IL-6, IL-1β, and TNF-α release in human blood monocytes and IL-2 and interferon-gamma in T cells. Immunopharmacology. 34:1996;27-37.
11. Maes M., Song C., Lin A.-H., Bonaccorso S., Kenis G.et al. Negative immunoregulatory effects of antidepressants: inhibition of interferon-γ and stimulation of interleukin-10 secretion. Neuropsychopharmacology. 20:1999;370-379.
12. Kubera M., Lin A., Kenis G., Bosmans E., van Bockstaele D., Maes M. Anti-inflammatory effects of antidepressants through suppression of the interferon-γ/interleukin-10 production ratio. J. Clin. Psychopharmacol. 21:2001;199-206.
13. Kubera M., Kenis G., Bosmans E., Scharpe S., Maes M. Effects of serotonin and serotonergic agonists and antagonists on the production of interferon-γ and interleukin-10. Neuropsychopharmacology. 23:2000;89-98.
14. Slużewska A., Rybakowski J.K., Laciak M., Mackiewicz A., Sobieska M., Wiktorowicz K. Interleukin-6 serum levels in depressed patients before and after treatment with fluoxetine. Ann. Acad. Sci. 762:1995;474-476.
15. Frommberger U.H., Bauer J., Haselbauer P., Fraulin A., Riemann D., Berger M. Interleukin-6 (IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remission. Eur. Arch. Psychiatry Clin. Neurosci. 247:1997;228-233.
16. Kubera M., Kenis G., Bosmans E., Zieba A., Dudek D., Nowak G.et al. Plasma levels of interleukin-6, interleukin-10, and interleukin-1 receptor antagonist in depression: comparison between the acute state and after remission. Pol. J. Pharmacol. 52:2000;237-241.
17. Slużewska A., Rybakowski J.K., Sobieska M., Bosmans E., Pollet H., Wiktorowicz K. Increased levels of alpha-1-acid glycoprotein and interleukin-6 in refractory depression. Depression. 39:1996;149-155.
18. Maes M., Meltzer H.Y., Bosmans E., Bergmans R., Vandoolaeghe E.et al. Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression. J. Affect. Disord. 34:1995;301-309.
19. Kubera M., Skowron-Cendrzak A., Mazur-Kolecka B., Bubak-Satora M., Basta-Kaim A., Laskowska-Bożsek H.et al. Stress-induced changes in muscarinic and β-adrenergic binding sites on rat thymocytes and lymphocytes. J. Neuroimmunol. 37:1992;229-236.
20. Kubera M, Maes M, Kim Y-K, Lasoń W. Effect of serotonin and serotonergic agonists and antagonists on the production of TNF-α and IL-6 in human whole blood. Psychiatry Res [in press].
21. Sebire G., Emilie D., Wallon C., Wry C., Devergne O.et al. In vitro production of IL-6, IL-1b, and tumor necrosis factor-a by human embryonic microglial and neural cells. J. Immunol. 150:1993;1517-1523.
22. Baumann H., Gauldi J. The acute phase response. Immunol. Today. 15:1994;74-80.
23. Barton B.E. The biological effects of interleukin-6. Med. Res. Rev. 16:1996;87-109.
24. Akira S., Taga T., Kishimoto T. Interleukin-6 in biology and medicine. Adv. Immunol. 54:1993;1-78.
25. Woloski B.M., Smith E.M., Meyer W.J. III, Fuller G.M., Blalock J.E. Corticotropin-releasing activity of monokines. Science. 230:1985;1035-1037.
26. Mihara M., Ikuta M., Koishihara Y., Ohsugi Y. Interleukin 6 inhibits delayed-type hypersensitivity and the development of adjuvant arthritis. Eur. J. Immunol. 21:1991;2327-2331.
27. Aderka D., Le J.M., Vilcek J. IL-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured human monocytes, U937 cells, and in mice. J. Immunol. 143:1989;3517-3523.
28. Starkie R., Ostrowski S.R., Jauffred S., Febbraio M., Pedersen B.K. Exercise and IL-6 infusion inhibit endotoxin-induced TNF-alpha production in humans. FASEB J. 2003;5.
29. Barton B.E., Shortall J., Jackson J.V. Interleukins 6 and 11 protect mice from mortality in a staphylococcal enterotoxin-induced toxic shock model. Infect. Immun. 64:1996;714-718.
30. Barkhudaryan N., Dunn A.J. Molecular mechanisms of actions of interleukin-6 on the brain, with special preference to serotonin and the hypothalamo-pituitary-adrenocortical axis. Neurochem. Res. 24:1999;1169-1180.
31. Zalcman S., Savina I., Wise R.A. Interleukin-6 increases sensitivity to the locomotor-stimulatin effects of amphetamine in rats. Brain Res. 847:1999;276-283.
32. Calapai G., Crupi A., Firenzuoli F., Inferrera G., Ciliberto G. Interleukin-6 involvement in antidepressant action of hypericum perforatum. Pharmacopsychiatry. 34(Suppl. 1):2001;58-60.
33. Kubera M., Maes M., Simbirtsev A., Mathison R. The effect of repeated fluoxetine and citalopram administration to C57BL/6 mice on cytokine release. Psychiatry Res. 96:2000;245-253.
34. Zangerle P.F., De Groot D., Lopez M., Meuleman R.J., Vrindts Y.et al. Direct stimulation of cytokines (IL-1 beta, TNF-alfa, IL-6, IL-2, IFN-gamma and GM-CSF) in whole blood. II. Application to rheumatoid arthritis and osteoarthritis. Cytokine. 4:1992;568-575.
35. De Groote D., Zangerle P.F., Gevaert Y., Fassotte M.F., Beguin Y.et al. Direct stimulation of cytokines (IL-1β, TNF-α, IL-6, IL-2, IFN-γ and GM-CSF) in whole blood: I. Comparison with isolated PBMC stimulation. Cytokine. 4:1992;239-248.
36. Kubera M., Cyrul W., Basta-Kaim A., Budziszewska B., Leskiewicz M., Holan V. Effect of repeated desipramine and fluoxetine administration on post-adjuvant arthritis. Pol. J. Pharmacol. 52:2000;229-235.
37. O'Connor T.M., O'Halloran D.J., Shanahan F. The stress response and the hypothalamic-pituitary-adrenal axis: from molecule to melancholia. QJM. 93:2000;323-333.
38. Bruunsgaard H., Pedersen A.N., Schroll M., Skinhoj P., Pedersen B.K. TNF-alfa, leptin, and lymphocyte function in human aging. Life Sci. 67:2000;2721-2731.
39. Bruunsgaard H., Pedersen M., Pedersen B.K. Aging and proinflammatory cytokines. Curr. Opin. Hematol. 8:2001;131-136.
40. Rink L., Cakman I., Kirchner H. Altered cytokines production in the elderly. Mech. Ageing Dev. 102:1998;199-209.